Session Information

  • WCLC 2021

    2021 World Conference on Lung Cancer

    Conference Program for 2021 the World Conference on Lung Cancer

    Presentation Date(s):  
    • September 8 - 14, 2021
    • Total Presentations: 1107

    All times listed are in Mountain Time MDT (UTC-6:00)

    PL - Plenary
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters
    WS - Workshops
    IS - Industry Symposium
    MTE - Meet the Expert
    BEDG - Brain Exchange Discussion Groups

Filter Results:

Show Only CME Accredited Sessions

  • +

    P70 - Tumor Biology and Systems Biology: Basic and Translational Science - Omics Analysis of Lung Cancer

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Tumor Biology and Systems Biology: Basic and Translational Science
    • +

      P70.01 - KRAS G12C Mutations Among NSCLC Patients Present With a High Intrerregional Variation, Indicating a Population Substructure

      00:00 - 00:00  |  Presenter: Andres Felipe Cardona Zorrilla

      • Abstract

      Loading...

    • +

      P70.02 - Clinicopathological and Genetic Ancestry Impact of TP53 Mutations in Brazilian Lung Adenocarcinoma Patients

      00:00 - 00:00  |  Presenter: Rodrigo de Oliveira Cavagna

      • Abstract

      Loading...

    • +

      P70.03 - Computational Omics Biology Model (CBM) Identifies Amplifications of Chromosome 6p to Predict Chemotherapy Resistance

      00:00 - 00:00  |  Presenter: Vamsidhar Velcheti

      • Abstract

      Loading...

    • +

      P70.04 - Results From a Patient Avatar Program Utilizing Murine Xenografts and Organoids After Neoadjuvant Therapy for Operable NSCLC

      00:00 - 00:00  |  Presenter: Caroline Huynh

      • Abstract

      Loading...

    • +

      P70.05 - Identification of Germline Mutations in Young Never Smokers With Lung Adenocarcinoma by Whole Exome Sequencing

      00:00 - 00:00  |  Presenter: Yang Zhang

      • Abstract

      Loading...

    • +

      P70.06 - m6A reader IGF2BP1 High Protein Expression level Indicates a Poor Recovery for Lung Adenocarcinoma Patients

      00:00 - 00:00  |  Presenter: Xuequan Wang

      • Abstract

      Loading...

    • +

      P70.07 - Examples of Population Kinetics (PopKin) Assessments of Progression-Free (PFS) and Overall Survival (OS)

      00:00 - 00:00  |  Presenter: DAVID James STEWART

      • Abstract

      Loading...

    • +

      P70.08 - Allelic Frequencies of Population Markers Correlate with KRAS G12C Prevalence: Considerations for Ancestries and Molecular Epidemiology

      00:00 - 00:00  |  Presenter: Andres Felipe Cardona Zorrilla

      • Abstract

      Loading...

    • +

      P70.09 - NOTCH1 Mutations in East Asian Patients With Non-Small-Cell Lung Cancer

      00:00 - 00:00  |  Presenter: Qian Wang

      • Abstract

      Loading...

    • +

      P70.10 - Prevalence of KRAS and Concomitant Mutations in Advanced Lung Adenocarcinoma Patients

      00:00 - 00:00  |  Presenter: Carlos Gil Ferreira

      • Abstract

      Loading...

    • +

      P70.11 - Prevalence and Clinicopathological Characteristics of ARID1A Mutations in East Asian Patients With Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenter: Qian Wang

      • Abstract

      Loading...

    • +

      P70.12 - NTRK Gene Fusion in Advanced Non Small Cell Lung Cancer at Pham Ngoc Thach Hospital - Viet Nam

      00:00 - 00:00  |  Presenter: NGUYEN SON LAM

      • Abstract

      Loading...

    • +

      P70.13 - Different Types of ERBB3 Mutations in Chinese Non-Small Cell Lung Cancer Patients

      00:00 - 00:00  |  Presenter: Qian Wang

      • Abstract

      Loading...

    • +

      P70.14 - PRKDC Mutations Recurrently Found in Non-Small Cell Lung Cancer in East Asian Patients

      00:00 - 00:00  |  Presenter: Qian Wang

      • Abstract

      Loading...

    • +

      P70.15 - Mutational Subtypes and Prognosis of East Asian Non-Small-Cell Lung Cancer Harboring NF2 Mutations

      00:00 - 00:00  |  Presenter: Qian Wang

      • Abstract

      Loading...

    • +

      P70.16 - Epidemiological Study of FGFR3 Mutations Among Non-Small Cell Lung Cancer Patients in China

      00:00 - 00:00  |  Presenter: Qian Wang

      • Abstract

      Loading...

    • +

      P70.17 - Molecular Characteristics and Prognosis TERT Mutations in East Asian Non-Small-Cell Lung Cancer Patients

      00:00 - 00:00  |  Presenter: Qian Wang

      • Abstract

      Loading...

    • +

      P70.18 - Distribution of GNAS Mutations in Chinese Patients With Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenter: Qian Wang

      • Abstract

      Loading...

    • +

      P70.19 - Clinicopathologic Characteristics of Patients With LRP1B Mutations in Chinese Non-Small Cell Lung Cancer Patients

      00:00 - 00:00  |  Presenter: Qian Wang

      • Abstract

      Loading...

    • +

      P70.20 - Impact of KRAS and Co-occurring Mutations on NSCLC Master Regulator Network as Determined by Computational Omics Biology Model.

      00:00 - 00:00  |  Presenter: Michael Castro

      • Abstract

      Loading...

  • +

    P71 - Tumor Biology and Systems Biology: Basic and Translational Science - Targeted Therapy of Lung Cancer

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Tumor Biology and Systems Biology: Basic and Translational Science
    • +

      P71.01 - Targeting HSPA1A in ARID2-Deficient Lung Adenocarcinoma

      00:00 - 00:00  |  Presenter: Xue Wang

      • Abstract

      Loading...

    • +

      P71.02 - Molecular and Cellular Dynamics of Drug-Tolerant Persister (DTP) Cells During Osimertinib Therapy in EGFR Mutant Lung Adenocarcinoma

      00:00 - 00:00  |  Presenter: Masashi Mikubo

      • Abstract

      Loading...

    • +

      P71.03 - A New Combination Therapy for FGFR1-Amplified Lung Cancer

      00:00 - 00:00  |  Presenter: Zhang Yang

      • Abstract

      Loading...

    • +

      P71.04 - MiR-1243 Increases Radiosensitivity in EGFR-TKI Resistant Non-Small Cell Lung Cancer Cells

      00:00 - 00:00  |  Presenter: yasi xu

      • Abstract

      Loading...

    • +

      P71.05 - Use of a Multiscale NSCLC Tumor Heterogeneity Model to Predict Tumor Growth Under Gefitinib

      00:00 - 00:00  |  Presenter: Adèle L'Hostis

      • Abstract

      Loading...

  • +

    IS04 - Industry Symposium Sponsored by Astrazeneca: Redefining the Treatment Journey in NSCLC with Immuno-oncology and EGFR-TKIs

    • 05:15 - 06:15
    • 9/09/2021
    • Location: Industry Symposium Auditorium via Industry Hub
    • Not for CME Credit
    • Type: Industry Supported Symposium
    • Track: N.A.
    • +

      IS04.01 - Welcome and Introduction

      05:15 - 05:20  |  Presenter: Yi-Long Wu

      • Abstract

      No abstract available for this presentation

    • +

      IS04.02 - Clinical Data with Immuno-oncology for Unresectable Stage III NSCLC

      05:20 - 05:35  |  Presenter: Suresh Senan

      • Abstract

      No abstract available for this presentation

    • +

      IS04.03 - Translating the Clinical Benefits of EGFR-TKIs across EGFRm NSCLC

      05:35 - 05:50  |  Presenter: Zhijie Wang

      • Abstract

      No abstract available for this presentation

    • +

      IS04.04 - Panel Discussion: Survivorship in NSCLC

      05:50 - 06:15

      • Abstract

      No abstract available for this presentation

  • +

    MTE03 - Meet the Expert - Mentorship for Established Thoracic Oncology Professionals

    • 05:15 - 06:15
    • 9/09/2021
    • Location: IASLC Booth via Industry Hub and Exhibit Hall
    • Not for CME Credit
    • Type: Meet the Expert Sessions
    • Track: N.A.
    • +

      MTE03.01 - Mentorship for Established Thoracic Oncology Professionals

      05:15 - 06:15  |  Presenter: Nan Wu

      • Abstract

      No abstract available for this presentation

  • +

    MTE04 - Meet the Expert - Thoracic Cancers Research and Resource Disparities among Geographic Regions

    • 05:15 - 06:15
    • 9/09/2021
    • Location: IASLC Booth via Industry Hub and Exhibit Hall
    • Not for CME Credit
    • Type: Meet the Expert Sessions
    • Track: N.A.
    • +

      MTE04.01 - Thoracic Cancers Research and Resource Disparities among Geographic Regions

      05:15 - 06:15  |  Presenter: David Harpole

      • Abstract

      No abstract available for this presentation

  • +

    PL02 - Plenary 2: Presidential Symposium (Japanese, Mandarin, Spanish Translation Available)

    • 06:30 - 08:00
    • 9/09/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Plenary
    • Track: N.A.
    • +

      PL02.01 - Durvalumab ± Tremelimumab + Chemotherapy as First-line Treatment for mNSCLC: Results from the Phase 3 POSEIDON Study

      06:30 - 06:40  |  Presenter: Melissa L Johnson

      • Abstract

      Loading...

    • +

      PL02.02 - Discussant

      06:40 - 06:47  |  Presenter: Julie Brahmer

      • Abstract

      No abstract available for this presentation

    • +

      PL02.03 - Lurbinectedin/Doxorubicin versus CAV or Topotecan in Relapsed SCLC Patients: Phase III Randomized ATLANTIS Trial

      06:47 - 06:57  |  Presenter: Luis Paz-Ares

      • Abstract

      Loading...

    • +

      PL02.04 - Discussant

      06:57 - 07:04  |  Presenter: Charles M Rudin

      • Abstract

      No abstract available for this presentation

    • +

      PL02.05 - IMpower010: Characterization of Stage IB-IIIA NSCLC Patients by Type and Extent of Therapy Prior to Adjuvant Atezolizumab

      07:04 - 07:14  |  Presenter: Nasser Altorki

      • Abstract

      Loading...

    • +

      PL02.06 - Discussant

      07:14 - 07:21  |  Presenter: Ichiro Yoshino

      • Abstract

      No abstract available for this presentation

    • +

      PL02.07 - Global Variability in Lung Cancer Deaths Attributable to Air Pollution

      07:21 - 07:31  |  Presenter: Christine Dorothy Berg

      • Abstract

      Loading...

    • +

      PL02.08 - Discussant

      07:31 - 07:38  |  Presenter: Joachim G.J.V. Aerts

      • Abstract

      No abstract available for this presentation

    • +

      PL02.09 - International Association for the Study of Lung Cancer (IASLC) Study of the Impacts of COVID-19 on International Lung Cancer Clinical Trials

      07:38 - 07:48  |  Presenter: Matthew Smeltzer

      • Abstract

      Loading...

    • +

      PL02.10 - Discussant

      07:48 - 07:55  |  Presenter: Marina Chiara Garassino

      • Abstract

      No abstract available for this presentation

    • +

      PL02.11 - Live Discussion with Speakers

      07:55 - 08:00

      • Abstract

      No abstract available for this presentation

  • +

    MA05 - Using Real World and Patient Reported Data to Identify Gaps and Needs for People with Lung Cancer: Impacts of the COVID-19 Pandemic, Treatment Patterns, and Psychosocial Impacts

    • 08:15 - 09:15
    • 9/09/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Mini Oral
    • Track: Patient Advocacy
    • +

      MA05.01 - Patients’ Experiences During COVID-19: Insights from The Second Global Lung Cancer Coalition Patient Experience Survey

      08:15 - 08:20  |  Presenter: Jackie Fenemore

      • Abstract

      Loading...

    • +

      MA05.02 - Impact of COVID-19 on Lung Cancer Care and Utilization of Patient Support Resources

      08:20 - 08:25  |  Presenter: Rashmi Acharya

      • Abstract

      Loading...

    • +

      MA05.03 - Considering the Continued Impact of the COVID-19 Pandemic on Patient Advocacy and Support Organisations

      08:25 - 08:30  |  Presenter: Matthew Peters

      • Abstract

      Loading...

    • +

      MA05.04 - Discussant

      08:30 - 08:45  |  Presenter: Anne-Marie Baird

      • Abstract

      No abstract available for this presentation

    • +

      MA05.05 - Treatment Patterns in Patients With EGFR-Positive Lung Cancer: A Real-World Patient-Report

      08:45 - 08:50  |  Presenter: Ivy B. Elkins

      • Abstract

      Loading...

    • +

      MA05.06 - The Psychosocial Impact of Lung Cancer – A European Perspective

      08:50 - 08:55  |  Presenter: Anne-Marie Baird

      • Abstract

      Loading...

    • +

      MA05.07 - Discussant

      08:55 - 09:10  |  Presenter: Jennifer C. King

      • Abstract

      No abstract available for this presentation

  • +

    OA06 - Prognosis and Staging

    • 08:15 - 09:15
    • 9/09/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Oral
    • Track: Staging/Pulmonary Medicine
    • +

      OA06.01 - Validation of the 8th Ed TNM: Invasive Size for Pathologic T Descriptor in Stage I-IIA Resected Nonmucinous Adenocarcinomas

      08:15 - 08:25  |  Presenter: Yan Li

      • Abstract

      Loading...

    • +

      OA06.02 - High-Grade Patterns Cause the Upstaging of Lung Adenocarcinomas From T1 to T2a: A Multicentric Analysis

      08:25 - 08:35  |  Presenter: Pietro Bertoglio

      • Abstract

      Loading...

    • +

      OA06.03 - PL1/2 Status is Associated With Worse Survival in T2 Non-Small Cell Lung Carcinoma: Is There A Need for a New Subgroup in the T Classification?

      08:35 - 08:45  |  Presenter: Ismail Sarbay

      • Abstract

      Loading...

    • +

      OA06.04 - Constructing a Global Molecular Database for Thoracic Malignancies: The IASLC Molecular Subcommittee Lung Cancer Dataset

      08:45 - 08:55  |  Presenter: Raymond Uyiosa Osarogiagbon

      • Abstract

      Loading...

    • +

      OA06.05 - Discussant

      08:55 - 09:05  |  Presenter: Jorge Alatorre

      • Abstract

      No abstract available for this presentation

    • +

      OA06.06 - Live Discussion with Speakers

      09:05 - 09:15

      • Abstract

      No abstract available for this presentation

  • +

    OA07 - What's On The Horizon for SCLC?

    • 08:15 - 09:15
    • 9/09/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Oral
    • Track: Small Cell Lung Cancer/ NET
    • +

      OA07.01 - Signatures of Plasticity and Immunosuppression in a Single-Cell Atlas of Human Small Cell Lung Cancer

      08:15 - 08:25  |  Presenter: Joseph Minhow Chan

      • Abstract

      Loading...

    • +

      OA07.02 - TAZ Regulates SCLC Phenotypic Transition and Metastasis

      08:25 - 08:35  |  Presenter: Yujuan Jin

      • Abstract

      Loading...

    • +

      OA07.03 - A Phase II Study of Frontline Rucaparib + Nivolumab in Platinum Sensitive ES SCLC: Interim Analysis

      08:35 - 08:45  |  Presenter: Aman Chauhan

      • Abstract

      Loading...

    • +

      OA07.04 - Discussant

      08:45 - 08:55  |  Presenter: Anne Chiang

      • Abstract

      No abstract available for this presentation

    • +

      OA07.05 - Live Discussion with Speakers

      08:55 - 09:15

      • Abstract

      No abstract available for this presentation

  • +

    MA06 - Differentiating Outcomes and Impact in Unresectable NSCLC

    • 09:30 - 10:30
    • 9/09/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Mini Oral
    • Track: Locally Advanced Non-Small Cell Lung Cancer
    • +

      MA06.01 - Death From Intercurrent Disease After Proton- Versus Photon-Based Chemoradiotherapy for Non-Small Cell Lung Cancer

      09:30 - 09:35  |  Presenter: Nikhil Yegya-Raman

      • Abstract

      Loading...

    • +

      MA06.02 - Impact of Heart and Lung Radiation Dose and Lymphopenia on Non-Small Cell Lung Cancer Outcomes

      09:35 - 09:40  |  Presenter: Jessica Little

      • Abstract

      Loading...

    • +

      MA06.03 - Deep Learning-Based Survival Prediction for Non-Small Cell Lung Cancer Patients Undergoing Radical Radiotherapy

      09:40 - 09:45  |  Presenter: Bilal Tahir

      • Abstract

      Loading...

    • +

      MA06.04 - Discussant

      09:45 - 10:00  |  Presenter: Megan Daly

      • Abstract

      No abstract available for this presentation

    • +

      MA06.05 - Patterns of Care in Maintenance Therapy in U.S. Patients Undergoing Definitive Chemoradiation for Stage 3 Non-Small Cell Lung Cancer (NCSLC)

      10:00 - 10:05  |  Presenter: Jason Liu

      • Abstract

      Loading...

    • +

      MA06.06 - Treatment Recommendations for Stage III NSCLC by 3 Dutch Multidisciplinary Tumor Boards Prior To, and Following the PACIFIC Trial

      10:05 - 10:10  |  Presenter: Merle I. Ronden

      • Abstract

      Loading...

    • +

      MA06.07 - Inferior Outcomes in Minority Patients with Unresectable Non-Small Cell Lung Cancer (NSCLC) After Durvalumab Consolidation Therapy

      10:10 - 10:15  |  Presenter: Franco Adjei-Baffour Dickson

      • Abstract

      Loading...

    • +

      MA06.08 - Discussant

      10:15 - 10:30  |  Presenter: Jyoti Patel

      • Abstract

      No abstract available for this presentation